Different patterns of FGFR1 and NCAM expressions might affect biological behaviour of renal cell tumours

被引:0
|
作者
Zivotic, M. [1 ]
Vjestica, J. [1 ]
Cirovic, S. [1 ]
Bosic, M. [1 ]
Dundjerovic, D. [1 ]
Markovic-Lipkovski, J. [1 ]
机构
[1] Fac Med Belgrade, Inst Pathol, Belgrade, Serbia
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
OFP-02-009
引用
收藏
页码:S6 / S6
页数:1
相关论文
共 27 条
  • [1] NCAM and FGFR1 coexpression and colocalization in renal tumors
    Cirovic, Sanja
    Vjestica, Jelena
    Mueller, Claudia A.
    Tatic, Svetislav
    Vasiljevic, Jovan
    Milenkovic, Sanja
    Mueller, Gerhard A.
    Markovic-Lipkovski, Jasmina
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (04): : 1402 - 1414
  • [2] FGFR1 overexpression and anti-FGFR compound sensitivity in renal cell carcinoma
    Tsimafeyeu, Ilya
    Stepanova, Evgenia
    Zaveleva, Elina
    Gordiyev, Marat
    Wynn, Nigel
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [3] NCAM and FGFR1 over-expressions are the earliest molecular changes upon TGF-β induced renal fibrosis in vitro-key targets for further strategies to ameliorate renal fibrosis
    Zivotic, M.
    Tampe, B.
    Xu, X.
    Tan, X.
    Nyamsuren, G.
    Mueller, C.
    Saito, S.
    Zeisberg, M.
    Mueller, G.
    Markovic-Lipkovski, J.
    VIRCHOWS ARCHIV, 2017, 471 : S22 - S22
  • [4] Overexpression of fibroblast growth factor receptors FGFR1 and FGFR2 in renal cell carcinoma
    Tsimafeyeu, Ilya
    Demidov, Lev
    Stepanova, Eugenia
    Wynn, Nigel
    Ta, Hung
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2011, 45 (03): : 190 - 195
  • [5] FGFR1 overexpression could impact on effi cacy of FGFR-targeted therapy in renal cell carcinoma
    Tsimafeyeu, Ilya
    Stepanova, Evgenia
    Khasanova, Alfi A.
    BJU INTERNATIONAL, 2014, 114 : 16 - 16
  • [6] Number and brightness analysis reveals that NCAM and FGF2 elicit different assembly and dynamics of FGFR1 in live cells
    Zamai, Moreno
    Trullo, Antonio
    Giordano, Marco
    Corti, Valeria
    Cuesta, Elvira Arza
    Francavilla, Chiara
    Cavallaro, Ugo
    Caiolfa, Valeria R.
    JOURNAL OF CELL SCIENCE, 2019, 132 (01)
  • [7] Fibroblast growth factor receptor 1 (FGFR1) expression and activation in clear cell renal cell carcinoma (ccRCC).
    Ho, T. H.
    Wang, F.
    Hoang, A.
    Tamboli, P.
    Jonasch, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [8] The impact of FGFR1 and FRS2α expression on sorafenib treatment in metastatic renal cell carcinoma
    Thai H Ho
    Xian-De Liu
    Yanqing Huang
    Carla L Warneke
    Marcella M Johnson
    Anh Hoang
    Pheroze Tamboli
    Fen Wang
    Eric Jonasch
    BMC Cancer, 15
  • [9] The impact of FGFR1 and FRS2α expression on sorafenib treatment in metastatic renal cell carcinoma
    Ho, Thai H.
    Liu, Xian-De
    Huang, Yanqing
    Warneke, Carla L.
    Johnson, Marcella M.
    Hoang, Anh
    Tamboli, Pheroze
    Wang, Fen
    Jonasch, Eric
    BMC CANCER, 2015, 15
  • [10] OM-RCA-01, an FGFR1 specific humanized antibody for the treatment of renal cell carcinoma (RCC).
    Tsimafeyeu, Ilya
    Zaveleva, Elina
    Low, Walter
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)